Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Randomized, Double-Blind, Multiple-Dose, Dose-Escalation Study to Evaluate the Pharmacokinetics of Huperzine A Oral Solution in Healthy Participants

NCT07784335 is registered in ClinicalTrials.gov with Wanbangde Pharmaceutical Group Co., LTD as lead sponsor.

NCT NCT07784335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Randomized, Double-Blind, Multiple-Dose, Dose-Escalation Study to Evaluate the Pharmacokinetics of Huperzine A Oral Solution in Healthy Participants
Lead sponsor
Wanbangde Pharmaceutical Group Co., LTD
Phase
Phase 1
Overall status
Not yet recruiting
Start date
August 25, 2026
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healhty